Disease-Free SurvivalSurvival RatePrognosisNeoplasm StagingTreatment OutcomeRetrospective StudiesSurvival AnalysisNeoplasm Recurrence, LocalCombined Modality TherapyBreast NeoplasmsKaplan-Meier EstimateFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsTumor Markers, BiologicalChemotherapy, AdjuvantLymphatic MetastasisRadiotherapy, AdjuvantProportional Hazards ModelsImmunohistochemistryCell SurvivalRadiotherapy DosageTime FactorsFluorouracilCarcinoma, Squamous CellNeoplasm InvasivenessCyclophosphamideColorectal NeoplasmsCarcinoma, Ductal, BreastMultivariate AnalysisCarcinomaRecurrenceLiver NeoplasmsAdenocarcinomaImmunoenzyme TechniquesReceptors, EstrogenProspective StudiesReceptor, erbB-2Predictive Value of TestsArea Under CurveGene Expression Regulation, NeoplasticRisk FactorsSurvivalROC CurveNeoplasm MetastasisCisplatinLung NeoplasmsAntineoplastic AgentsGraft SurvivalNeoplasm GradingVincristineDoxorubicinDisease ProgressionNeoadjuvant TherapyBone NeoplasmsRemission InductionEtoposideDrug Administration ScheduleCohort StudiesChemoradiotherapyCarcinoma, Non-Small-Cell LungOvarian NeoplasmsSalvage TherapyReceptors, ProgesteroneMethotrexateSarcomaRadiotherapyHead and Neck NeoplasmsAge FactorsFree RadicalsLymphoma, Non-HodgkinCarboplatinPrednisoneLymph Node ExcisionBrachytherapyActuarial AnalysisHodgkin DiseaseCarcinoma, HepatocellularLymph NodesNeoplasms, Germ Cell and EmbryonalNeoplasm ProteinsPancreatic NeoplasmsHematopoietic Stem Cell TransplantationRisk AssessmentTransplantation, AutologousOsteosarcomaNeoplasm, ResidualPaclitaxelTransplantation, HomologousBrain NeoplasmsStomach NeoplasmsTamoxifenRectal NeoplasmsAntineoplastic Agents, HormonalAntibodies, MonoclonalDose-Response Relationship, DrugCell Line, TumorReverse Transcriptase Polymerase Chain ReactionUterine Cervical NeoplasmsDose FractionationDeoxycytidine